In the spring of 2010, the Office of Management and Budget (OMB) issued a directive to federal agencies regarding the implementation of the Research Performance Progress Report (RPPR) module in an effort to standardize the information that is being requested and collected from the funded agencies, reduce administrative burden and costs on the grantees and the funding agency, and streamline the data that is collected across all Federal agencies.
The NIH began requiring its grantees to submit all Type 5 progress reports, including non-SNAP eligible and multi-project grants, via the RPPR module in the eRA Commons as of October 17, 2014.
The Principal Investigator may submit either a SNAP- or NON-SNAP-eligible Type 5 Progress Report. The Notice of Award document specifies which type of progress report is to be submitted for each award in the Terms and Conditions section. Please see definitions below for SNAP and NON-SNAP:
Streamlined Non-Competing Award Process (SNAP): is a streamlined process that includes a number of provisions that modify annual progress reports, NOAs, and financial reports. Unobligated balances of under 25% are automatically carried over to the next budget year, without prior approval. All NIH award notices identify whether the grant is subject to or excluded from SNAP. For more information on SNAP, click here.
Non-streamlined Non-Competing Award Process (Non-SNAP): is not a streamlined process or subject to the SNAP provisions and typically includes a detailed budget in the RPPR module in eRA Commons.
Note: Effective February 16, 2011, the campus delegated submission authority to the Principal Investigator for all SNAP-eligible progress reports. Internal paperwork is not required for these proposals.
Note: Effective Immediately, RPPR due notices will no longer be sent to Fund Managers directly. Instead, HS SPPO will email the HS Contacts listserv when the RPPR due reports are posted to the website.
Prior to supplementing any Paid Direct from federal funds need to ensure the terms and condition allow and request prior approval. Note: NIH does not allow this. You will need to use discretionary funds if you plan to or are supplementing your Paid Direct.
Additionally, you must disclose on the NIH application and RPPR that the Paid Direct visiting foreign student or scholar is working on the grant
For G.9 Foreign component report, here is approved template language you can use on your RPPR:
- X were visiting graduate students from X Foreign University. They were financially supported by a scholarship from the foreign government, which covered their living expenses in San Diego, with no fund brought here to support their research work in the lab at UCSD. All the research work and experimental data reported in our most recent paper were done in Dr.’s X UCSD lab.
If the PI has been delegated authority to submit SNAP-eligible Progress Reports to the NIH directly, and a SNAP-eligible noncompeting continuation is due to the Sponsor, then no internal documentation needs to be prepared. The PI, and all Key Personnel on the project, will still need to submit their FCOI disclosures to the Conflict of Interest Office.
If the award involves animal and/or human subjects, protocol verification will be conducted once the NOA is received by OCGA.
SNAP-eligible progress reports are due 45 days prior to the start of the next Budget Period
For Progress Reports that are non-SNAP eligible, Central Office review and submission is still necessary as Central Office holds delegation of authority to submit all budgetary information to the Sponsor; the PI will not have the option to Submit appear in that type of RPPR progress report.
In the case of a non-SNAP eligible Progress Report, please refer to the Minimum Requirements Page for what the HS SPPO analysts will need in order to review and submit the Type 5 application.
Please see the
Review Priorities document which outlines both the department's and HS SPPO's responsibilities in reviewing non-SNAP RPPRs.
HS SPPO will also verify IRB protocols and IACUC protocols, if needed, at time of progress report submission.
Non-SNAP eligible progress reports are due 60 days prior to the start of the next budget period. FCOI disclosures must also be submitted to the Conflict of Interest Office.
For a list of all upcoming progress reports due for submission, please see below:
BOUTELLE, KERRI N
Cue-Reward Learning and Weight Gain in Youth
BRISTOW, CLAIRE C
Molecular epidemiology of HIV and Neisseria gonorrhoeae in the context of drug resistance
|CALIFANO, JOSEPH A
|5R01CA204264-03||A novel point of care test for oral and oropharyngeal cancer risk||11/15/2018|
|CHEN, JU ||5R01HL130295-
|BAG3 in Cardiac function and disease||11/15/2018|
|CROTTY ALEXANDER, LAURA ELISE||5R01HL137052-03||Electronic Cigarette Vapor Inhalation Adversely Affects Lung Cellular and Physiologic Function and Alters Systemic Inflammatory Pathways||11/15/2018|
|DENNIS, EDWARD A||5R01GM020501-43||Action of Lipolytic Enzymes||11/15/2018|
|GALLO, RICHARD L||5R01AI116576-05||Skin barrier function and the microbiome||11/15/2018|
|GILSON, MICHAEL K.||5R01GM070064-15||BindingDB: Data and Tools for Drug Discovery, Chemical Biology and Systems Pharmacology||11/15/2018|
|GINSBERG, MARK HOWARD||5R35HL139947-02||Deconvoluting the Vascular Adhesome||11/01/2018|
|GUTKIND, J SILVIO ||5R01DE026644-03||Targeting Signaling Vulnerabilities for Oral Cancer Prevention||11/15/2018|
|HALBERSTADT, ADAM L||5R01DA041336-03||The Next Generation of Hallucinogens: A New Class of Synthetic Psychoactive Drugs||11/15/2018|
|HAMILTON, BRUCE A||5R01GM086912-17||Genetic Modifier Activity and Network Properties of Nxf1||11/15/2018|
|HAMILTON, BRUCE A||5T32GM008666-21||Training Program in Basic and Clinical Genetics||11/15/2018|
|HENRY, BROOK ||5R01DA043430-03||Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain||11/15/2018|
|HEVNER, ROBERT F||5R01NS092339-05||Development and Malformations of the Dentate Gyrus||11/15/2018|
|HOGAN, MICHAEL C||5R01AR069577-03||Assessing and Alleviating Skeletal Muscle Ca2+ Handling Dysfunction in Sarcopenia||11/15/2018|
|INSEL, PAUL A||5T32GM007198-45||Medical Scientist Training Program||11/15/2018|
|ISAACSON, JEFFRY S||5R01DC015239-03||Dynamic sensory representations in adult auditory cortex||11/15/2018|
|LEWINSKI, MARY KATHLEEN||5K08AI112394-05||HIV-1 Modulation of the Ubiquitinome and Its Effects on Cell-to-Cell Transmission||11/15/2018|
|MARQUEZ, BECKY ||5K01HL130726-04||Improving communication and collaboration for weight management in mother-daughter dyads||11/15/2018|
|NIGAM, SANJAY K||5R01DK109392-03||The Role of OAT1 in Uremia||11/15/2018|
|NOVICK, PETER JAY||5R01GM035370-34||Genetics of secretion in yeast||11/15/2018|
|OHNO-MACHADO, LUCILA ||5R01GM118609-03||Decentralized differentially-private methods for dynamic data release and analysis||11/15/2018|
|PATEL, HEMAL H||5T32GM121318-03||Interdisciplinary Anesthesiology Research Training Program||11/15/2018|
|RIVERA-NIEVES, JESUS ||5R01DK108670-04||Novel Traffic-targeted Therapies for IBD||11/15/2018|
|RODWELL, TIMOTHY CHARLES||5R21AI135756-02||Culture-free next generation sequencing for rapid detection of drug-resistant tuberculosis||11/15/2018|
|ROSENFELD, MICHAEL G||5R01DK018477-43||Enhancer Connectomes in Regulation of Gene Expression||11/15/2018|
|SAJTI, ENIKO ||5K08HL140198-02||Epigenomics of mononuclear phagocytes in prematurity associated lung disease||11/15/2018|
|SALEM, RANY ||5R00HL122515-05||Methods for Genetic Association Analysis of Longitudinal and Multiple Phenotypes||11/15/2018|
|SEN, GEORGE L||5R01AR066530-05||Regulators of Epidermal Growth and Differentiation||11/15/2018|
|SHI, YUYAN ||5R01DA042290-03||Neighborhood Physical, Economic, and Socioeconomic Environment In Relation to Marijuana Use and Disorder||11/15/2018|
|SMITH, DAVID MITCHELL||5R01AI120009-05||High-throughput Deep Sequencing Assay to Reliably Measure the HIV Reservoir during Antiretroviral Therapy||11/15/2018|
|TRAVER, DAVID ||5R01HL135205-03||Wnt signaling in hematopoietic development||11/15/2018|
|WARD, SAMUEL RICHARD||5R21AR072523-02||Promotion of Skeletal Muscle Recovery Using an Extracellular Matrix Hydrogel in a Rabbit Model of Chronic Rotator Cuff Injury||11/15/2018|
|WERTHEIM, JOEL OKRENT||5R01AI135992-02||Automation and Evaluation of Real-Time Transmission Network-Based HIV Prevention Services in New York City||11/15/2018|
|ACEVES, SEEMA S.|
|Mentoring Patient Oriented Research in Allergic Eosinophilic Gastrointestinal Disorders|
|ADVANI, SUNIL J||5R37CA215081-02||Elucidation and therapeutic exploitation of PAK mediated radioresistance||10/15/2018|
|ALPERIN, MARIANNA ||5R21HD094566-02||Injectable Tissue-Specific Extracellular Matrix Hydrogel for Pelvic Skeletal Muscle Regeneration Following Birth Injury||10/15/2018|
|BENSON, CONSTANCE ANN||5UM1AI069432-13||The UCSD CD4 Collaborative Clinical Trial Unit||10/01/2018|
|BURNS, JANE C||5R01HL140898-02||Innate Immune Activation and Endothelial Cell Dysfunction in Acute Kawasaki Disease||10/15/2018|
|CHANG, JOHN T||5R01AI129973-02||Role of proteasome activity in adaptive immunity||10/15/2018|
|CHEN, JU ||5R01HL130452-04||Adipocytes and cardiac remodeling||10/15/2018|
|CHI, NEIL C||5R01HL139709-02||Regulatory Mechanisms of Cardiomyocyte Lineage Specification||10/15/2018|
|DULAWA, STEPHANIE C||5R21MH115395-02||Using in vivo CRISPR-Cas9 to dissect the neural circuits mediating compulsive behaviors||10/15/2018|
|DURDEN, DONALD ||5R01CA215651-02||Dual PI3K/BRD4 inhibitory chemotype for maximum inhibition of Myc and cancer||10/15/2018|
|ECKMANN, LARS ||5R33AI121571-03||Nanoparticle decoys for treating infections with enterotoxin-producing pathogens||10/15/2018|
|ERNST, PETER B.||5R01AI079145-08||The Role of the Adenosine Receptor in Th Cell Development and Function||10/15/2018|
|GOLLAN, TAMAR ||5R01DC011492-09||Bilingual Alzheimer's Disease||10/15/2018|
|GUAN, KUN-LIANG ||5R01GM051586-25||Protein phosphorylation and growth factor function||10/15/2018|
|JAMIESON, CATRIONA HELEN MACLEOD||5R01CA205944-03||Characterization of the Role of ADAR1 in Oncogenic Transformation of Progenitors||10/15/2018|
|KERR, JACQUELINE ||5R01HL125405-05||Peer Empowerment Program for Physical Activity in Low Income & Minority Seniors||10/01/2018|
|MALHOTRA, ATUL ||5T32HL134632-03||Training in the Next Generation in Respiratory Science||10/01/2018|
|MESIROV, JILL P.||5R01GM074024-15||Supporting Integrative Genomic Analysis Users with GenePattern||10/15/2018|
|OHNO-MACHADO, LUCILA ||5R01HL136835-02||Protecting Privacy and Facilitating Shared Access of Clinical and Genetic Data of Special Populations||10/15/2018|
|ROSENFELD, MICHAEL G||5R01CA213371-03||Repressive Transcriptional Programs in Breast Cancer||10/15/2018|
|ROSENFELD, MICHAEL G||5R37DK039949-37||Genomic and Translational Approaches to Neuroendocrine Switching Events||10/15/2018|
|SHAHIDI, BAHAR ||5R03HD094598-02||3D Quantification of Exercise-Induced Recruitment in Pathological Paraspinal Muscles||10/15/2018|
|SHAO, JIANHUA ||5R01DK113007-02||Hypoadiponectinemia and Gestational Diabetes||10/15/2018|
|SPECTOR, STEPHEN A||5UM1AI069536-13||HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)||10/01/2018|
|TUKEY, ROBERT H||5R01GM126074-02||Novel regulatory events that control expression of the UGT1A1 gene||10/15/2018|
|YAKSH, TONY L||5R01NS099338-03||Sex, Stress and Immunity in the Acute to Chronic Pain Transition||10/15/2018|
|ZHENG, BINHAI ||5P30NS047101-16||University of California San Diego Neuroscience Microscopy Imaging Core||10/01/2018|